Thank you for your interest in viewing the Midyear ALS Research Review webinar!
June 13, 2018
The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.
This session will specifically outline what we think people should be on the lookout for in 2018, including where we stand with Masitinib, CopperATSM, NP001, NurOwn, AT-1501 and other potential treatments.
We will also spend some time providing a short overview of the current basic research focuses in ALS occurring across the globe, such as biomarkers, etc.
This session will be recorded and made available online following the webinar.
Please provide the following information so we can continue to make our Webinars relevant for the entire ALS community
* = Required Fields
Register now for our upcoming webinar on May 10th at 6pm: FDA approves Radicava - What do we need to know?
#WHATWOULDYOUGIVE to #ENDALS?
For ALS Awareness Month, join our #InThreeWords campaign on social media.
You can be a hero and give to ALS TDI to help us get more promising treatments out of our lab and into people living with ALS.
November 27 is
You've taken the challenge, now help
move promising treatments out of our
lab and into people living with ALS.
The 2018 Combined Federal Campaign has officially launched!
Yes, I have ALS. But I'm still Kate. I still consider myself a superhero, and with our powers combined, we can end ALS. -Kate